Housing conditions and microbial environment do not affect the efficacy of vaccines for treatment of opioid use disorders in mice and rats

References

• NSDUH. 2018 (accessed 2021 Jan 15). https://www.samhsa.gov/data/release/2018-national-survey-drug-use-and-health-nsduh-releases
   Google Scholar
• CDC. 2020 (accessed 2021 Jan 15). http://wonder.cdc.gov
   Google Scholar
• Network CHA Increase in fatal drug overdoses across the United States driven by synthetic opioids before and during the COVID-19 pandemic. (2020).
   Google Scholar
• Pravetoni M. Biologics to treat substance use disorders: current status and new directions. Hum Vaccin Immunother. 2016;12(12):3005–19. doi:10.1080/21645515.2016.1212785.
   PubMed Web of Science ®Google Scholar
• Stowe GN, Vendruscolo LF, Edwards S, Schlosburg JE, Misra KK, Schulteis G, Mayorov AV, Zakhari JS, Koob GF, Janda KD, et al. A vaccine strategy that induces protective immunity against heroin. J Med Chem. 2011;54(14):5195–204. doi:10.1021/jm200461m.
   PubMed Web of Science ®Google Scholar
• Pravetoni M, Le Naour M, Tucker AM, Harmon TM, Hawley TM, Portoghese PS, Pentel PR. Reduced antinociception of opioids in rats and mice by vaccination with immunogens containing oxycodone and hydrocodone haptens. J Med Chem. 2013;56(3):915–23. doi:10.1021/jm3013745.
   PubMed Web of Science ®Google Scholar
• Anton B, Leff P. A novel bivalent morphine/heroin vaccine that prevents relapse to heroin addiction in rodents. Vaccine. 2006;24(16):3232–40. doi:10.1016/j.vaccine.2006.01.047.
   PubMed Web of Science ®Google Scholar
• Pravetoni M, Comer SD. Development of vaccines to treat opioid use disorders and reduce incidence of overdose. Neuropharmacology. 2019;158:107662. doi:10.1016/j.neuropharm.2019.06.001.
   PubMed Web of Science ®Google Scholar
• Bonese KF, Wainer BH, Fitch FW, Rothberg RM, Schuster CR. Changes in heroin self-administration by a rhesus monkey after morphine immunisation. Nature. 1974;252(5485):708–10. doi:10.1038/252708a0.
   PubMed Web of Science ®Google Scholar
• Tenney RD, Blake S, Bremer PT, Zhou B, Hwang CS, Poklis JL, Janda KD, Banks ML. Vaccine blunts fentanyl potency in male rhesus monkeys. Neuropharmacology. 2019;158:107730. doi:10.1016/j.neuropharm.2019.107730.
   PubMed Web of Science ®Google Scholar
• Townsend EA, Bremer PT, Faunce KE, Negus SS, Jaster AM, Robinson HL, Janda KD, Banks ML. Evaluation of a dual fentanyl/heroin vaccine on the antinociceptive and reinforcing effects of a fentanyl/heroin mixture in male and female rats. ACS Chem Neurosci. 2020;11(9):1300–10. doi:10.1021/acschemneuro.0c00064.
   PubMed Web of Science ®Google Scholar
• Sulima A, Jalah R, Antoline JFG, Torres OB, Imler GH, Deschamps JR, Beck Z, Alving CR, Jacobson AE, Rice KC, et al. A stable heroin analogue that can serve as a vaccine hapten to induce antibodies that block the effects of heroin and its metabolites in rodents and that cross-react immunologically with related drugs of abuse. J Med Chem. 2018;61(1):329–43. doi:10.1021/acs.jmedchem.7b01427.
   PubMed Web of Science ®Google Scholar
• Baruffaldi F, Kelcher AH, Laudenbach M, Gradinati V, Limkar A, Roslawski M, Birnbaum A, Lees A, Hassler C, Runyon S, et al. Preclinical efficacy and characterization of candidate vaccines for treatment of opioid use disorders using clinically viable carrier proteins. Mol Pharm. 2018;15(11):4947–62. doi:10.1021/acs.molpharmaceut.8b00592.
   PubMedGoogle Scholar
• Bremer PT, Schlosburg JE, Lively JM, Janda KD. Injection route and TLR9 agonist addition significantly impact heroin vaccine efficacy. Mol Pharm. 2014;11(3):1075–80. doi:10.1021/mp400631w.
   PubMedGoogle Scholar
• Crouse B, Robinson C, Huseby Kelcher A, Laudenbach M, Abrahante JE, Pravetoni M. Mechanisms of interleukin 4 mediated increase in efficacy of vaccines against opioid use disorders. NPJ Vaccines. 2020;5(1):99. doi:10.1038/s41541-020-00247-7.
   PubMed Web of Science ®Google Scholar
• Raleigh MD, Laudenbach M, Baruffaldi F, Peterson SJ, Roslawski MJ, Birnbaum AK, Carroll FI, Runyon SP, Winston S, Pentel PR, et al. Opioid dose- and route-dependent efficacy of oxycodone and heroin vaccines in rats. J Pharmacol Exp Ther. 2018;365(2):346–53. doi:10.1124/jpet.117.247049.
   PubMed Web of Science ®Google Scholar
• Pravetoni M, Vervacke JS, Distefano MD, Tucker AM, Laudenbach M, Pentel PR. Effect of currently approved carriers and adjuvants on the pre-clinical efficacy of a conjugate vaccine against oxycodone in mice and rats. Plos One. 2014;9(5):e96547. doi:10.1371/journal.pone.0096547.
   PubMed Web of Science ®Google Scholar
• Robinson C, Baehr C, Schmiel SE, Accetturo C, Mueller DL, Pravetoni M. Alum adjuvant is more effective than MF59 at prompting early germinal center formation in response to peptide-protein conjugates and enhancing efficacy of a vaccine against opioid use disorders. Hum Vaccin Immunother. 2019;15(4):909–17. doi:10.1080/21645515.2018.1558697.
   PubMed Web of Science ®Google Scholar
• Nguyen JD, Hwang CS, Grant Y, Janda KD, Taffe MA. Prophylactic vaccination protects against the development of oxycodone self-administration. Neuropharmacology. 2018;138:292–303. doi:10.1016/j.neuropharm.2018.06.026.
   PubMed Web of Science ®Google Scholar
• Raleigh MD, Baruffaldi F, Peterson SJ, Le Naour M, Harmon TM, Vigliaturo JR, Pentel PR, Pravetoni M. A fentanyl vaccine alters fentanyl distribution and protects against fentanyl-induced effects in mice and rats. J Pharmacol Exp Ther. 2019;368(2):282–91. doi:10.1124/jpet.118.253674.
   PubMed Web of Science ®Google Scholar
• Robinson C, Gradinati V, Hamid F, Baehr C, Crouse B, Averick S, Kovaliov M, Harris D, Runyon S, Baruffaldi F, et al. Therapeutic and prophylactic vaccines to counteract fentanyl use disorders and toxicity. J Med Chem. 2020;63(23):14647–67. doi:10.1021/acs.jmedchem.0c01042.
   PubMed Web of Science ®Google Scholar
• Hwang CS, Bremer PT, Wenthur CJ, Ho SO, Chiang S, Ellis B, Zhou B, Fujii G, Janda KD. Enhancing efficacy and stability of an antiheroin vaccine: examination of antinociception, opioid binding profile, and lethality. Mol Pharm. 2018;15(3):1062–72. doi:10.1021/acs.molpharmaceut.7b00933.
   PubMedGoogle Scholar
• Laudenbach M, Baruffaldi F, Vervacke JS, Distefano MD, Titcombe PJ, Mueller DL, Tubo NJ, Griffith TS, Pravetoni M. The frequency of naive and early-activated hapten-specific B cell subsets dictates the efficacy of a therapeutic vaccine against prescription opioid abuse. J Immunol. 2015;194(12):5926–36. doi:10.4049/jimmunol.1500385.
   PubMed Web of Science ®Google Scholar
• Laudenbach M, Baruffaldi F, Robinson C, Carter P, Seelig D, Baehr C, Pravetoni M. Blocking interleukin-4 enhances efficacy of vaccines for treatment of opioid abuse and prevention of opioid overdose. Sci Rep. 2018;8(1):5508. doi:10.1038/s41598-018-23777-6.
   PubMedGoogle Scholar
• Hwang CS, Smith LC, Wenthur CJ, Ellis B, Zhou B, Janda KD. Heroin vaccine: using titer, affinity, and antinociception as metrics when examining sex and strain differences. Vaccine. 2019;37(30):4155–63. doi:10.1016/j.vaccine.2019.05.061.
   PubMed Web of Science ®Google Scholar
• Kosten TA, Shen XY, Kinsey BM, Kosten TR, Orson FM. Attenuation of cocaine-induced locomotor activity in male and female mice by active immunization. Am J Addict. 2014;23(6):604–07. doi:10.1111/j.1521-0391.2014.12152.x.
   PubMed Web of Science ®Google Scholar
• Pulendran B. Immunology taught by vaccines. Science. 2019;366(6469):1074–75. doi:10.1126/science.aau6975.
   PubMed Web of Science ®Google Scholar
• Collins N, Belkaid Y. Do the microbiota influence vaccines and protective immunity to pathogens? Engaging our endogenous adjuvants. Cold Spring Harb Perspect Biol. 2018;10(2):a028860. doi:10.1101/cshperspect.a028860.
   PubMed Web of Science ®Google Scholar
• Praharaj I, John SM, Bandyopadhyay R, Kang G. Probiotics, antibiotics and the immune responses to vaccines. Philos Trans R Soc Lond B Biol Sci. 2015;370(1671):20140144. doi:10.1098/rstb.2014.0144.
   PubMed Web of Science ®Google Scholar
• de Jong SE, Olin A, Pulendran B. The impact of the microbiome on immunity to vaccination in humans. Cell Host Microbe. 2020;28:169–79. doi:10.1016/j.chom.2020.06.014.
   PubMed Web of Science ®Google Scholar
• Banerjee S, Sindberg G, Wang F, Meng J, Sharma U, Zhang L, Dauer P, Chen C, Dalluge J, Johnson T, Roy S. Opioid-induced gut microbial disruption and bile dysregulation leads to gut barrier compromise and sustained systemic inflammation. Mucosal Immunol. 2016;9:1418–28. doi:10.1038/mi.2016.9.
   PubMed Web of Science ®Google Scholar
• Wang F, Meng J, Zhang L, Johnson T, Chen C, Roy S. Morphine induces changes in the gut microbiome and metabolome in a morphine dependence model. Sci Rep. 2018;8(1):3596. doi:10.1038/s41598-018-21915-8.
   PubMed Web of Science ®Google Scholar
• Kiraly DD, Walker DM, Calipari ES, Labonte B, Issler O, Pena CJ, Ribeiro EA, Russo SJ, Nestler EJ. Alterations of the Host microbiome affect behavioral responses to cocaine. Sci Rep. 2016;6:35455. doi:10.1038/srep35455.
   PubMed Web of Science ®Google Scholar
• Meckel KR, Kiraly DD. A potential role for the gut microbiome in substance use disorders. Psychopharmacology (Berl). 2019;236(5):1513–30. doi:10.1007/s00213-019-05232-0.
   PubMed Web of Science ®Google Scholar
• Lee K, Vuong HE, Nusbaum DJ, Hsiao EY, Evans CJ, Taylor AMW. The gut microbiota mediates reward and sensory responses associated with regimen-selective morphine dependence. Neuropsychopharmacology. 2018;43(13):2606–14. doi:10.1038/s41386-018-0211-9.
   PubMed Web of Science ®Google Scholar
• Beura LK, Hamilton SE, Bi K, Schenkel JM, Odumade OA, Casey KA, Thompson EA, Fraser KA, Rosato PC, Filali-Mouhim A, et al. Normalizing the environment recapitulates adult human immune traits in laboratory mice. Nature. 2016;532(7600):512–16. doi:10.1038/nature17655.
   PubMed Web of Science ®Google Scholar
• Pravetoni M, Le Naour M, Harmon TM, Tucker AM, Portoghese PS, Pentel PR. An oxycodone conjugate vaccine elicits drug-specific antibodies that reduce oxycodone distribution to brain and hot-plate analgesia. J Pharmacol Exp Ther. 2012;341(1):225–32. doi:10.1124/jpet.111.189506.
   PubMed Web of Science ®Google Scholar
• Raleigh MD, Peterson SJ, Laudenbach M, Baruffaldi F, Carroll FI, Comer SD, Navarro HA, Langston TL, Runyon SP, Winston S, et al. Safety and efficacy of an oxycodone vaccine: addressing some of the unique considerations posed by opioid abuse. PLoS One. 2017;12(12):e0184876. doi:10.1371/journal.pone.0184876.
   PubMed Web of Science ®Google Scholar
• Gohl DM, Vangay P, Garbe J, MacLean A, Hauge A, Becker A, Gould TJ, Clayton JB, Johnson TJ, Hunter R, et al. Systematic improvement of amplicon marker gene methods for increased accuracy in microbiome studies. Nat Biotechnol. 2016;34(9):942–49. doi:10.1038/nbt.3601.
   PubMed Web of Science ®Google Scholar
• Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet J. 2011;17(1):3. doi:10.14806/ej.17.1.200.
   Google Scholar
• Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJA, Holmes SP. DADA2: high-resolution sample inference from illumina amplicon data. Nat Methods. 2016;13(7):581–83. doi:10.1038/nmeth.3869.
   PubMed Web of Science ®Google Scholar
• vegan: Community Ecology Package (2017).
   Google Scholar
• Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. doi:10.1186/s13059-014-0550-8.
   PubMed Web of Science ®Google Scholar
• Langille MG, Zaneveld J, Caporaso JG, McDonald D, Knights D, Reyes JA, Clemente JC, Burkepile DE, Vega Thurber RL, Knight R, et al. Predictive functional profiling of microbial communities using 16S rRNA marker gene sequences. Nat Biotechnol. 2013;31(9):814–21. doi:10.1038/nbt.2676.
   PubMed Web of Science ®Google Scholar
• Boyer EW. Management of opioid analgesic overdose. N Engl J Med. 2012;367(2):146–55. doi:10.1056/NEJMra1202561.
   PubMed Web of Science ®Google Scholar
• Clapp M, Aurora N, Herrera L, Bhatia M, Wilen E, Wakefield S. Gut microbiota’s effect on mental health: the gut-brain axis. Clin Pract. 2017;7:987. doi:10.4081/cp.2017.987.
   PubMed Web of Science ®Google Scholar
• Shreiner AB, Kao JY, Young VB. The gut microbiome in health and in disease. Curr Opin Gastroenterol. 2015;31(1):69–75. doi:10.1097/MOG.0000000000000139.
   PubMed Web of Science ®Google Scholar
• Arndt A, Hoffacker P, Zellmer K, Goecer O, Recks MS, Kuerten S. Conventional housing conditions attenuate the development of experimental autoimmune encephalomyelitis. Plos One. 2014;9(6):e99794. doi:10.1371/journal.pone.0099794.
   PubMed Web of Science ®Google Scholar
• Letson HL, Morris J, Biros E, Dobson GP. Conventional and specific-pathogen free rats respond differently to anesthesia and surgical trauma. Sci Rep. 2019;9(1):9399. doi:10.1038/s41598-019-45871-z.
   PubMedGoogle Scholar
• Abolins S, King EC, Lazarou L, Weldon L, Hughes L, Drescher P, Raynes JG, Hafalla JCR, Viney ME, Riley EM, et al. The comparative immunology of wild and laboratory mice, mus musculus domesticus. Nat Commun. 2017;8(1):14811. doi:10.1038/ncomms14811.
   PubMedGoogle Scholar
• Zhang P, Yang M, Chen C, Liu L, Wei X, Zeng S. Toll-like receptor 4 (TLR4)/opioid receptor pathway crosstalk and impact on opioid analgesia, immune function, and gastrointestinal motility. Front Immunol. 2020;11:1455. doi:10.3389/fimmu.2020.01455.
   PubMed Web of Science ®Google Scholar
• Kim YS, Unno T, Kim BY, Park MS. Sex differences in gut microbiota. World J Mens Health. 2020;38:48–60. doi:10.5534/wjmh.190009.
   PubMedGoogle Scholar